DD291995A5 - Verfahren zur herstellung von aethern der verbindung 1-benzyl-3-hydroxy-methyl-indazol mit aliphatischen 2-hydroxysaeuren - Google Patents

Verfahren zur herstellung von aethern der verbindung 1-benzyl-3-hydroxy-methyl-indazol mit aliphatischen 2-hydroxysaeuren Download PDF

Info

Publication number
DD291995A5
DD291995A5 DD90337657A DD33765790A DD291995A5 DD 291995 A5 DD291995 A5 DD 291995A5 DD 90337657 A DD90337657 A DD 90337657A DD 33765790 A DD33765790 A DD 33765790A DD 291995 A5 DD291995 A5 DD 291995A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
compound
reaction mixture
methyl
crr
Prior art date
Application number
DD90337657A
Other languages
German (de)
English (en)
Inventor
Bruno Silvestrini
Leandro Baiocchi
Original Assignee
�������@��������@�������@��������@���������@�K@�K@�K@�K@�K@�K@�K@�Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@��������@�������@��������@���������@�K@�K@�K@�K@�K@�K@�K@�Kk�� filed Critical �������@��������@�������@��������@���������@�K@�K@�K@�K@�K@�K@�K@�Kk��
Publication of DD291995A5 publication Critical patent/DD291995A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DD90337657A 1989-02-07 1990-02-07 Verfahren zur herstellung von aethern der verbindung 1-benzyl-3-hydroxy-methyl-indazol mit aliphatischen 2-hydroxysaeuren DD291995A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (1)

Publication Number Publication Date
DD291995A5 true DD291995A5 (de) 1991-07-18

Family

ID=11261479

Family Applications (2)

Application Number Title Priority Date Filing Date
DD90337657A DD291995A5 (de) 1989-02-07 1990-02-07 Verfahren zur herstellung von aethern der verbindung 1-benzyl-3-hydroxy-methyl-indazol mit aliphatischen 2-hydroxysaeuren
DD90342349A DD295363A5 (de) 1989-02-07 1990-02-07 Verfahren zur herstellung von 1-benzyl-indazol-3-yl-zwischenprodukten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD90342349A DD295363A5 (de) 1989-02-07 1990-02-07 Verfahren zur herstellung von 1-benzyl-indazol-3-yl-zwischenprodukten

Country Status (36)

Country Link
US (2) US4999367A (hu)
EP (1) EP0382276B1 (hu)
JP (1) JP2870925B2 (hu)
KR (1) KR0145525B1 (hu)
CN (2) CN1046505C (hu)
AR (1) AR247386A1 (hu)
AT (1) ATE127115T1 (hu)
AU (1) AU624895B2 (hu)
BG (1) BG50273A3 (hu)
CA (1) CA2009503C (hu)
CZ (1) CZ280121B6 (hu)
DD (2) DD291995A5 (hu)
DE (2) DE69021902T2 (hu)
DK (1) DK0382276T3 (hu)
EG (1) EG19170A (hu)
ES (1) ES2020171T3 (hu)
FI (1) FI102678B (hu)
GE (1) GEP19971030B (hu)
GR (2) GR910300073T1 (hu)
HU (1) HU204793B (hu)
IL (1) IL93132A (hu)
IN (1) IN170957B (hu)
IT (1) IT1230441B (hu)
LT (1) LT3604B (hu)
LV (1) LV10612B (hu)
NZ (1) NZ232258A (hu)
PE (1) PE25091A1 (hu)
PH (1) PH26552A (hu)
PL (2) PL163720B1 (hu)
PT (1) PT93067B (hu)
RO (1) RO106252B1 (hu)
RU (3) RU2066318C1 (hu)
SK (1) SK278441B6 (hu)
UA (1) UA26852C2 (hu)
YU (1) YU47943B (hu)
ZA (1) ZA90644B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
AR070813A1 (es) 2008-03-07 2010-05-05 Acraf Nuevos derivados de 1- bencil -3-hidroximetilindazol y su utilizacion en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1
LT2262778T (lt) 2008-03-07 2019-11-11 Acraf 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydant ligas, pagrįstas mcp-1, cxcr1 ir p40 raiška
EP2254869B1 (en) * 2008-03-07 2017-05-31 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Neue 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of cx3cr1 und p40
CA2765461C (en) 2009-08-03 2017-04-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.S.P.A. Process for the preparation of 1-benzyl-3-hydr0xymethyl-1h-indaz0le and its derivatives and required magnesium intermediates
UA108742C2 (uk) 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CA3095012C (en) 2012-05-01 2023-02-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2013171316A1 (en) 2012-05-18 2013-11-21 Sanofi Pyridine derivatives and their use in the treatment of conditions associated with pathological thrombus formation
RU2645344C2 (ru) 2012-05-18 2018-02-21 Санофи Производные пиразола и их применение в качестве lpar5 антагонистов
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
EP3990433A4 (en) * 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
AU4906690A (en) 1990-08-16
ZA90644B (en) 1991-01-30
CN1034016C (zh) 1997-02-12
DE382276T1 (de) 1991-11-28
RU2066318C1 (ru) 1996-09-10
DD295363A5 (de) 1991-10-31
DE69021902T2 (de) 1996-05-23
EP0382276B1 (en) 1995-08-30
HUT53088A (en) 1990-09-28
GR3018165T3 (en) 1996-02-29
YU20690A (sh) 1992-07-20
DE69021902D1 (de) 1995-10-05
LV10612B (en) 1995-08-20
AU624895B2 (en) 1992-06-25
US5112986A (en) 1992-05-12
JP2870925B2 (ja) 1999-03-17
PE25091A1 (es) 1991-08-17
UA26852C2 (uk) 1999-12-29
PT93067B (pt) 1995-12-29
IN170957B (hu) 1992-06-20
YU47943B (sh) 1996-07-24
IT8947620A0 (it) 1989-02-07
LV10612A (lv) 1995-04-20
CN1046505C (zh) 1999-11-17
RO106252B1 (ro) 1993-03-31
HU204793B (en) 1992-02-28
IL93132A (en) 1994-05-30
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
SK56390A3 (en) 1997-05-07
ES2020171T3 (es) 1995-12-01
EG19170A (en) 1994-11-30
EP0382276A3 (en) 1990-12-12
GR910300073T1 (en) 1991-11-15
PT93067A (pt) 1990-08-31
PL163730B1 (pl) 1994-04-29
JPH02240065A (ja) 1990-09-25
BG50273A3 (en) 1992-06-15
FI102678B (fi) 1999-01-29
ATE127115T1 (de) 1995-09-15
CA2009503A1 (en) 1990-08-07
DK0382276T3 (da) 1996-01-15
LT3604B (en) 1995-12-27
KR0145525B1 (ko) 1998-08-17
CA2009503C (en) 2000-04-11
US4999367A (en) 1991-03-12
CZ56390A3 (en) 1995-06-14
HU900689D0 (en) 1990-04-28
PH26552A (en) 1992-08-19
RU2055071C1 (ru) 1996-02-27
CN1044810A (zh) 1990-08-22
SK278441B6 (en) 1997-05-07
ES2020171A4 (es) 1991-08-01
IL93132A0 (en) 1990-11-05
LTIP872A (en) 1995-03-27
CN1088201A (zh) 1994-06-22
IT1230441B (it) 1991-10-23
NZ232258A (en) 1991-06-25
CZ280121B6 (cs) 1995-11-15
KR900012913A (ko) 1990-09-03
EP0382276A2 (en) 1990-08-16
RU2044729C1 (ru) 1995-09-27
AR247386A1 (es) 1994-12-29
PL163720B1 (pl) 1994-04-29
FI900577A0 (fi) 1990-02-06

Similar Documents

Publication Publication Date Title
EP0013376B1 (de) Ein Isoxazolderivat, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Mittel
DD291995A5 (de) Verfahren zur herstellung von aethern der verbindung 1-benzyl-3-hydroxy-methyl-indazol mit aliphatischen 2-hydroxysaeuren
DE3047142C2 (de) Basische 1,7,7-Trimethylbicyclo[2,2,1]heptyläther, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
EP0400011A1 (de) Neue phenylethanolamine.
DE1443599A1 (de) Ungesaettigte Amine
CH616923A5 (hu)
DE2311570C2 (de) 4-Aminochinoline, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2704989A1 (de) Arzneimittel, in diesen enthaltene neue verbindungen und verfahren zu ihrer herstellung
DE2656088A1 (de) Neues benzylalkoholderivat und verfahren zu seiner herstellung
DE2307828A1 (de) (4-benzothiazolyl)-phenylessigsaeuren
DE2253914C3 (de) Chromon-3-acrylsaeuren, verfahren zu ihrer herstellung sowie diese verbindung enthaltende arzneimittel
DE2535599C2 (de) Substituierte Zimtsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE2253748A1 (de) Carboxamidobenzoesaeuren
DE1568848C3 (de) Trans-Isomere von Alkenderivaten und Verfahren zu Ihrer Herstellung
DE3104387A1 (de) Neue indanderivate, verfahren zu ihrer herstellung und ihre verwendung
DE2725245A1 (de) Methylaminderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen
DE2146676A1 (de) Cyclopropano- eckige Klammer auf b eckige Klammer zu -tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung
AT213872B (de) Verfahren zur Herstellung neuer basischer Phenoläther und ihrer Salze
DE2609574B2 (de) 1-(4-fluor-3-trifluormethylthio- phenyl)-piperazin, dessen salze, verfahren zu dessen herstellung und arzneimittel
CH624398A5 (en) Process for the preparation of aroylphenylnaphthalenes
EP0009153B1 (de) Halogenierte Delta-Hydroxycarbonsäurederivate, Verfahren zu deren Herstellung und diese Derivate enthaltende neue Medikamente
DE2236005C3 (de) Dibenzo- eckige Klammer auf d,f eckige Klammer zu -dioxepin- eckige Klammer auf 1,3 eckige Klammer zu -derivate und deren pharmakologisch verträgliche Salze, sowie Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0007347A1 (de) Lipidsenkende Alkylenglykolderivate und Verfahren zu ihrer Herstellung.
AT251565B (de) Verfahren zur Herstellung von neuen Carbonsäuren
AT367031B (de) Verfahren zur herstellung von neuen omega-(2-(nniederalkyl-benzamido)-phenyl)-alkans[uren und ihren salzen

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20100208